About this trial
The Endocrinology Unit of the IRCCS San Raffaele Hospital is dedicated to establishing a prospective single-center registry with data from patients undergoing vitamin D supplementation, initiating their first visit to the outpatient unit until December 2029. 1000 patients will be enrolled, aligning with the unit's recent patient influx for hypovitaminosis D.
The registry's goal is to assess the epidemiological trend, identify risk factors, and evaluate the diagnostic and therapeutic clinical management strategies for hypovitaminosis D. It will involve collecting clinical, laboratory, and historical data during outpatient visits, adhering to the standard diagnostic and therapeutic protocols for endocrine-metabolic diseases. This data collection is expected to continue for a duration of ten years.
Eligibility criteria
Qualifiers
Adult men and women (age ≥ 18 years) regardless of fertility status and pregnancy/breastfeeding conditions
Vitamin D supplementation, with any formulation and dosage
Signing of informed consent
Disqualifiers
Patients unable to understand and sign informed consent.
Trial design
Treatments tested in this trial
- supplementary treatment with vitamin D